Hematology, Transfusion and Cell Therapy

Journal Information
ISSN / EISSN : 2531-1379 / 2531-1387
Published by: Elsevier BV (10.1016)
Total articles ≅ 1,504
Current Coverage
Archived in

Latest articles in this journal

, Karen Miranda Chequer, Clara Martins Azevedo Eyer Thomaz, Gustavo Marcio Silvino Assunção, Felipe Duarte Augusto, Gilberto De Almeida Fonseca Filho
Hematology, Transfusion and Cell Therapy; https://doi.org/10.1016/j.htct.2021.07.005

, Aisha Khan
Hematology, Transfusion and Cell Therapy; https://doi.org/10.1016/j.htct.2021.07.006

: The SARS-CoV-2 pandemic has been affecting the health and economic, as well as social, life of the entire globe since the end of 2019. The virus causes COVID-19, with a wide range of symptoms among the infected individuals, from asymptomatic infection to mortality. This, along with a high infection rate, prompted efforts to investigate the potential mechanisms of the different clinical manifestations caused by SARS-CoV-2 among the infected populations.
Sunil Kumar Sukla, Pradeep Kumar Mohanty, Siris Patel, Kishalaya Das, Mrutyunjay Hiregoudar, Uttam Kumar Soren,
Hematology, Transfusion and Cell Therapy; https://doi.org/10.1016/j.htct.2021.06.012

During pregnancy, the iron requirement increases to meet the optimal growth of the fetus and prevent iron deficiency anemia-related complications in the mother. However, in sickle cell disease (SCD) primarily due to repeated blood transfusions and hemolysis-induced recycling of iron, its supplementation during pregnancy remains questionable and may be harmful.
Back to Top Top